Results from a national survey from Roswell Park Comprehensive Cancer Center seem to suggest that nearly one in five people diagnosed with cancer prefer...
According to the latest analysis by DataM Intelligence, the Next-Generation Multiple Myeloma Therapies Market Size was valued at USD 22.03 billion in 2023, increased to USD 23.13 billion in...
Nanjing IASO Biotechnology has signed an agreement with Korea's GC Cell to introduce the CAR-T therapy Equecabtagene Autoleucel (Fucaso®) to the South Korean market...
Liposarcoma market growth is driven by increasing awareness and earlier diagnosis, expanding the pool of treatable patients. Advances in molecular profiling and targeted therapies...
Kytopen, a company providing continuous-flow cellular engineering technologies, and BlueWhale Bio, which focuses on accelerating the growth and adoption of cell-based therapies by transforming...
AbbVie and Capstan Therapeutics, a clinical-stage biotechnology company, have signed a definitive agreement under which AbbVie will acquire Capstan, including its lead asset, CPTX2309,...